HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,247,141 | +3.8% | 527,430 | -1.3% | 0.01% | 0.0% |
| Q2 2023 | $45,518,108 | +0.6% | 534,627 | -2.2% | 0.01% | 0.0% |
| Q1 2023 | $45,248,053 | +2.7% | 546,804 | -2.4% | 0.01% | 0.0% |
| Q4 2022 | $44,060,990 | -3.1% | 560,216 | -8.8% | 0.01% | -9.1% |
| Q3 2022 | $45,472,000 | +17.0% | 614,235 | +3.0% | 0.01% | +22.2% |
| Q2 2022 | $38,866,000 | +0.4% | 596,306 | -2.6% | 0.01% | +28.6% |
| Q1 2022 | $38,704,000 | +24.5% | 612,216 | +4.5% | 0.01% | +16.7% |
| Q4 2021 | $31,080,000 | -24.1% | 585,983 | +1.1% | 0.01% | -25.0% |
| Q3 2021 | $40,929,000 | +10.3% | 579,815 | +4.2% | 0.01% | +14.3% |
| Q2 2021 | $37,091,000 | -31.9% | 556,578 | +13.4% | 0.01% | -36.4% |
| Q1 2021 | $54,482,000 | -7.6% | 490,784 | -1.1% | 0.01% | -15.4% |
| Q4 2020 | $58,951,000 | +35.3% | 496,431 | -0.6% | 0.01% | +18.2% |
| Q3 2020 | $43,580,000 | -10.5% | 499,490 | -8.1% | 0.01% | -15.4% |
| Q2 2020 | $48,696,000 | -17.4% | 543,721 | -8.1% | 0.01% | -35.0% |
| Q1 2020 | $58,944,000 | -10.1% | 591,457 | +3.7% | 0.02% | +17.6% |
| Q4 2019 | $65,555,000 | -12.1% | 570,547 | -3.5% | 0.02% | -15.0% |
| Q3 2019 | $74,547,000 | -3.1% | 590,987 | -7.6% | 0.02% | -4.8% |
| Q2 2019 | $76,939,000 | +16.4% | 639,361 | -15.4% | 0.02% | +10.5% |
| Q1 2019 | $66,125,000 | -19.6% | 755,877 | -8.1% | 0.02% | -26.9% |
| Q4 2018 | $82,296,000 | -16.0% | 822,546 | -3.8% | 0.03% | +4.0% |
| Q3 2018 | $97,942,000 | +39.0% | 854,775 | +8.8% | 0.02% | +31.6% |
| Q2 2018 | $70,460,000 | +45.2% | 785,681 | +18.4% | 0.02% | +46.2% |
| Q1 2018 | $48,542,000 | +25.7% | 663,513 | -0.2% | 0.01% | +30.0% |
| Q4 2017 | $38,622,000 | +26.1% | 664,964 | -2.6% | 0.01% | +25.0% |
| Q3 2017 | $30,620,000 | +7.5% | 682,426 | -5.4% | 0.01% | 0.0% |
| Q2 2017 | $28,496,000 | -7.2% | 721,639 | -4.6% | 0.01% | 0.0% |
| Q1 2017 | $30,697,000 | +5.9% | 756,590 | +5.0% | 0.01% | 0.0% |
| Q4 2016 | $28,974,000 | +19.1% | 720,738 | +7.3% | 0.01% | +14.3% |
| Q3 2016 | $24,332,000 | +31.3% | 671,969 | +5.1% | 0.01% | +16.7% |
| Q2 2016 | $18,530,000 | -20.0% | 639,149 | -3.4% | 0.01% | -14.3% |
| Q1 2016 | $23,150,000 | +10.9% | 661,784 | +2.2% | 0.01% | +16.7% |
| Q4 2015 | $20,878,000 | -0.7% | 647,603 | -0.4% | 0.01% | 0.0% |
| Q3 2015 | $21,016,000 | -4.2% | 650,224 | +22.6% | 0.01% | 0.0% |
| Q2 2015 | $21,943,000 | -7.0% | 530,534 | +1.0% | 0.01% | 0.0% |
| Q1 2015 | $23,592,000 | +21.5% | 525,192 | +1.3% | 0.01% | +20.0% |
| Q4 2014 | $19,410,000 | +7.9% | 518,707 | +0.7% | 0.01% | 0.0% |
| Q3 2014 | $17,984,000 | -51.0% | 514,997 | -50.5% | 0.01% | 0.0% |
| Q2 2014 | $36,722,000 | +112.7% | 1,040,828 | +96.4% | 0.01% | 0.0% |
| Q1 2014 | $17,268,000 | -47.8% | 529,842 | -32.5% | 0.01% | -44.4% |
| Q4 2013 | $33,068,000 | -46.9% | 784,918 | -49.7% | 0.01% | 0.0% |
| Q3 2013 | $62,238,000 | +90.5% | 1,560,624 | +97.5% | 0.01% | -10.0% |
| Q2 2013 | $32,674,000 | – | 790,197 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |